BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18949449)

  • 21. t(1;14) and t(11;18) in the differential diagnosis of Waldenström's macroglobulinemia.
    Ye H; Chuang SS; Dogan A; Isaacson PG; Du MQ
    Mod Pathol; 2004 Sep; 17(9):1150-4. PubMed ID: 15143341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells.
    Sagaert X; Laurent M; Baens M; Wlodarska I; De Wolf-Peeters C
    Mod Pathol; 2006 Feb; 19(2):225-32. PubMed ID: 16341151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
    Kuo SH; Cheng AL
    Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.
    Ye H; Liu H; Attygalle A; Wotherspoon AC; Nicholson AG; Charlotte F; Leblond V; Speight P; Goodlad J; Lavergne-Slove A; Martin-Subero JI; Siebert R; Dogan A; Isaacson PG; Du MQ
    Blood; 2003 Aug; 102(3):1012-8. PubMed ID: 12676782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
    Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
    J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.
    Liu H; Ruskon-Fourmestraux A; Lavergne-Slove A; Ye H; Molina T; Bouhnik Y; Hamoudi RA; Diss TC; Dogan A; Megraud F; Rambaud JC; Du MQ; Isaacson PG
    Lancet; 2001 Jan; 357(9249):39-40. PubMed ID: 11197361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas.
    Kaneko Y; Sakurai S; Hironaka M; Sato S; Oguni S; Sakuma Y; Sato K; Sugano K; Saito K
    Gut; 2003 May; 52(5):641-6. PubMed ID: 12692046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.
    Maes B; Demunter A; Peeters B; De Wolf-Peeters C
    Blood; 2002 Feb; 99(4):1398-404. PubMed ID: 11830492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.
    Wündisch T; Thiede C; Morgner A; Dempfle A; Günther A; Liu H; Ye H; Du MQ; Kim TD; Bayerdörffer E; Stolte M; Neubauer A
    J Clin Oncol; 2005 Nov; 23(31):8018-24. PubMed ID: 16204012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
    Kuo SH; Cheng AL; Lin CW; Hsu CH; Wu MS; Yeh KH; Tzeng YS; Chen LT
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1387-95. PubMed ID: 21465313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. t(11;18)(q21;q21) in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in stomach: a study of 48 cases.
    Wang G; Auerbach A; Wei M; Dow N; Barry TS; Hodge L; Schaffer D; Sobin LH; Aguilera NS
    Mod Pathol; 2009 Jan; 22(1):79-86. PubMed ID: 18820661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
    Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
    J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
    Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
    World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma.
    Nakamura S; Matsumoto T; Nakamura S; Jo Y; Fujisawa K; Suekane H; Yao T; Tsuneyoshi M; Iida M
    J Clin Pathol; 2003 Jan; 56(1):36-42. PubMed ID: 12499431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
    Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
    Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.
    Raderer M; Streubel B; Wöhrer S; Häfner M; Chott A
    Gut; 2006 May; 55(5):616-8. PubMed ID: 16299027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study.
    Montalban C; Santón A; Redondo C; García-Cosio M; Boixeda D; Vazquez-Sequeiros E; Norman F; de Argila CM; Alvarez I; Abraira V; Bellas C
    Ann Oncol; 2005 Sep; 16(9):1539-44. PubMed ID: 15946976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric lymphomas: genetics and resistance to H. pylori eradication.
    Isaacson PG; Du MQ
    Verh Dtsch Ges Pathol; 2003; 87():116-22. PubMed ID: 16888902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.